title: Leptin levels and clinical outcomes in patients with systemic inflammatory response syndrome.
authors.affiliation: Jerusalem, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Sviri
authors.affiliation: Jerusalem, Israel.
authors.forename: T
authors.initials: T
authors.lastname: Neuman
authors.affiliation: Jerusalem, Israel.
authors.forename: E M
authors.initials: EM
authors.lastname: Berry
authors.affiliation: Jerusalem, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Bayya
authors.affiliation: Jerusalem, Israel.
authors.forename: D M
authors.initials: DM
authors.lastname: Linton
authors.affiliation: Jerusalem, Israel.
authors.forename: P V
authors.initials: PV
authors.lastname: van Heerden
authors.affiliation: Jerusalem, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Stav
authors.affiliation: Jerusalem, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Theodur
authors.affiliation: Jerusalem, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Avraham
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D020738:Leptin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D015850:Interleukin-6; D020738:Leptin; D014409:Tumor Necrosis Factor-alpha